1. Charpentier S，Ducass JL，Cournot M，et al. Clinical assessment of ischemia -modified albumin and heart fatty acid-binding protein in the early diagnosis of non- ST -elevation acute coronary syndrome in he emergency department[J]. Acad Emerg Med，2010，17（1）：27-35.

2. 苏建友，鞠少卿，朱建华，等.新的心肌缺血标志物-缺血修饰白蛋白，国外医学临床生物化学与检验学分册，2005，26 :795.

3. Bhagavan NV，Lai EM，Rios PA.Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and Myocardial infarction[J]. Clin Chem，2003，49（4）:581-585.

4. Bar-Or D，Curds G，Rao N，et al. Characterization of the CO ²⁺ and NI ²⁺ binding amino-acid residuces of the N-terminus. of human albumin[J]. Eur J Biochem，2001，268:42～47.

5. Bar-Or D，Lau E，Winkler JV. A novel assay for cobalt albumin binding and it s potential as a marker for myocardial ischemia -preliminary report. J Emerg Med，2000，19 :311.

6. Bali L，Cuisset T，Giorgi R，et al. Prognostic value of ischemia-modified albumin in patients with non-ST-segment elevation acute coronary syndromes [J]. Arch Cardiovasc Dis，2008，101（10 ）:645 - 651.

7. Dominguez-Rodriguez A，Kaski JC，Abreu-Gonzalez P，et al. Role of ischemia modified albumin to ST-segment resolution after mechanical reperfusion in patients with ST-segment elevation myocardial infarction [J]. Atherosclerosis，2009，203（2）：576 - 580.

8. Sinha MK，Roy D，Gaze DC. Role of ischemia modified albumin，a new biochemical marker of myocardial ischaemia，in the early diagnosis of acute coronary syndromes [J]. Emerg Med，2004，21（1）:29-34.

9. Bar-Or D，Rael LT，Bar-Or R，et al. The cobalt-albumin binding assay ：insight s into its mode of action. Clin Chim Acta，2008 ，387 :120.

10. Van Belle E，Dallongeville J，Vicaut E，et al.Ischemia-modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study[J]. Am Heart J，2010，159（4）: 570-576.

11. Hjortsh J S，Dethlefsen C，Kristensen SR，et al.Determinants of the release pattern of ischemia-modified albumin in acute ST-elevation myocardial infarction treated with primary PCI[J].Scand J Clin Lab Invest，2010，70（4）:244-251.

12. 藏军仁，任海燕，张爱华，等.经皮冠状动脉介入治疗有无侧支循环时血浆缺血修饰白蛋白的变化及其意义[J].临床和实验医学杂志，2008，7（9）:82-83.

13. Karahan SC，Koramaz I，Altun G，et al.Ischemia-modified albumin reduction after coronary bypass surgery is associated with the cardio protective efficacy of cold-blood cardio plgia enriched with N-acetyl cysteine：a preliminary study[J]. Eur Surg Res，2010，44（1）:30-36.

14. WorsterA，Devereaux PJ，Heels-Ansdell D，et al.Capability of ischemia modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome[J]. CMAJ，2005，172（13）:1685-1690.

15. Talwalkar SS，Bon Homme M，Miller JJ，et al. Ischemia modified albumin，a marker of acute ischemic events：a pilot study[J].Ann Clin Lab Sci，2008，38（2）:132-137.